DTMs used by U.S. patients diagnosed with MS 2016 by administration route
This statistic displays the percentage of U.S. patients diagnosed with multiple sclerosis using disease-modifying therapies (DMTs) in 2016, by route of administration. As of that year, some 18 percent of surveyed MS patients stated that they never used prescribed injectable disease-modifying therapies.
